|
|
- 4548 Market Street Suite M-20 Philadelphia, PA 19139
- 136 Delaware Road London W9 2LL UK
|
| |
|
TTC Employee to Represent USA in Beijing Olympics
|
After
trouncing the competition, TTC,llc employee, Micah
Boyd, will compete in the Men's Eight at the Olympics
this summer in Beijing.
Rowing
is one of the 28 sports contested at the Summer Olympic
Games added to the roster of events in 1900.
For most competitors and spectators alike, the Olympics is considered the premier sporting event. Requiring core balance, physical strength, and cardiovascular endurance, Micah maintains a rigorous training regiment. Since early November, Boyd has traveled and trained with the US Rowing National Team in an effort to obtain a seat in one of the Olympic boats.
Originally from Minnesota, Micah went to school at the University of Wisconsin, Madison where he rowed for four years before moving to Philadelphia to join both us at TTC and Penn AC, a competitive rowing club in Philadelphia. After rowing out of Penn AC for three years, Micah moved to Princeton, NJ, in the fall of 2007, where he trained day in and day out with the top rowers in the |
|
|
country, vying for one of fourteen available spots for the Olympics. On June 27, 2008, Micah's yearlong efforts were rewarded when the official Olympic rowing squad was announced. Micah will sit in the Four Seat of the Men's Eight, the premier US boat, at the Beijing Olympics.
Previous interviews attest to Micah's modest approach to the magnitude of the competition. He is quoted by the StarTribune as saying, "I've never considered myself a world-class athlete. It just doesn't sound right."
Boyd, along with his fellow Olympians, will have to settle for dreams of Medals until August 9th, when the rowing events begin.
Keep watch for the newsletter as we update you on Micah's progress.
back to the top | |
|
CRO CostPro™
|
|
CRO CostPro™, TTC's new clinical outsourcing cost benchmarking and negotiating system, enables sponsors to forecast, budget and negotiate the cost to outsource clinical trials. Via a secure electronic RFP module sponsors are able to request, analyze and process proposals from CROs directly through the database. CostPro contains extensive clinical trial outsourcing cost data for over 50 countries where clinical trials are currently ongoing.
CRO CostPro™ requires no change in the methods a company uses to request proposals from CROs. Utilizing a master bid grid to underpin the system, CostPro enables all companies to continue using their activity descriptions, yet still determine Fair Market Value by benchmarking against the rest of the industry.
Created in close conjunction with users from pharmaceutical companies and CROs around the world, CRO CostPro™ is designed with the following benefits: |
- Easy Access and User Friendly Interface.
- Quick Long Range, as well as Detailed Cost Forecasting.
- Ability to Attach Study Documents. (i.e. protocol, scope of work, timelines, etc.)
- Side by Side Cost Comparison for all RFPs received per study.
Utilizing detailed activity based costing methodology CRO CostPro™ provides cost details for every activity outsourced to a CRO. (i.e. project plan development, CRF development, site monitoring visit, data entry, report writing, etc.) The database also provides summary cost data for the various categories found in proposals. (i.e. project management, data management, medical monitoring, biostatistics, medical writing, etc.)
For more information about CRO CostPro™, please contact help@ttc-llc.com. | |
|
back to the top | |
|
Outlook for Outsourcing
|
|
Outsourcing of clinical trials will remain an important component of most pharmaceutical companies. Pharmaceutical and CRO outsourcing professionals are in general agreement about how pharmaceutical companies will use outsourcing in the coming years, with a couple of noteworthy exceptions. Drawing upon a survey of over 400 outsourcing professionals, we used a five field classification of CRO activities.
- Preferred
providers:
A smaller group of CROs, who have first
preference on studies, and for whom a rate
card has been developed for.
- Functional providers: The CRO takes responsibility for a functional area such as data management across most or all clinical trials.
- Single-area outsourcing: A provider takes responsibility for a particular aspect, for example, biostatistics, of an individual clinical trial.
- In-sourcing: A sponsor company contracts individuals to perform certain activities, such as monitoring.
- Full-service providers: The CRO assumes responsibility for all outsourced aspects of an individual clinical trial.
Large and small pharmaceutical companies expect to use CROs in fairly similar fashions, although larger sponsor companies anticipate making greater use of in-sourcing than do smaller companies. |
|
|
|
There is broad agreement between pharmaceutical company and CRO respondents in how the outsourcing landscape will look in five years. However, while both pharmaceutical company and CRO survey participants expect that pharmaceutical companies will make extensive use of preferred providers, sponsor companies are particularly likely to emphasize the use of these types of CRO relationships. In addition pharmaceutical company survey participants foresee making more use in-sourcing than CROs imagine will be the case.
For more information about the study or if you would like to receive publications which highlight the results, please email reprints@ttc-llc.com. |
back to the top | |
"Our help desk is available whenever you have a question or need assistance with GrantPlan®. Simply email an inquiry to help@ttc-llc.com and one of our client service professionals will respond to you in a timely manner." |
